Back | Next |
home / stock / psti / psti message board
Subject | By | Source | When |
---|---|---|---|
I was worried about you Zzatt. You never | Scott999 | investorshub | 04/18/2023 11:55:12 AM |
I was worried about you Zzatt. You never | Scott999 | investorshub | 04/18/2023 11:55:11 AM |
Can anyone say schadenfreude LMAO.999 really knows how | zzaatt | investorshub | 04/18/2023 1:32:30 AM |
Its going to vanish into oblivion without a | Scott999 | investorshub | 04/17/2023 5:14:40 PM |
Total lack of interest. Nobody even cared | midastouch017 | investorshub | 04/17/2023 4:56:18 PM |
Even Mr. Zzientist seems to have given up | Scott999 | investorshub | 04/17/2023 4:26:54 PM |
Hell only use that to see how he | Scott999 | investorshub | 04/14/2023 3:02:24 PM |
Maybe he can ask CHAT GBT how to | sekander | investorshub | 04/14/2023 3:00:27 PM |
Maybe tomorrow theyre gong to announce their next | Scott999 | investorshub | 04/14/2023 1:42:03 AM |
Tweet Tweet | FDApproved | investorshub | 04/11/2023 3:22:14 PM |
TASE IS CLOSED ON.... | FDApproved | investorshub | 04/04/2023 1:51:02 PM |
Try as they might, try as they may, | sekander | investorshub | 04/04/2023 1:56:53 AM |
Any day now they will be participating in | Scott999 | investorshub | 04/03/2023 9:30:44 PM |
Tweet Tweet | FDApproved | investorshub | 04/03/2023 12:03:01 PM |
April Company Presentation Is Out | FDApproved | investorshub | 04/02/2023 12:43:49 PM |
Theyre gonna get tired of this 30 day | Scott999 | investorshub | 04/01/2023 3:39:33 AM |
Less than 20K$ in trades and it moves | sekander | investorshub | 04/01/2023 1:39:58 AM |
Whos pulling out some favours to try and | Scott999 | investorshub | 03/31/2023 6:39:44 PM |
Who needs revenue when youre pulling in crazy | Scott999 | investorshub | 03/29/2023 3:15:46 PM |
They may at least get some revenue from | sekander | investorshub | 03/29/2023 1:22:34 AM |
News, Short Squeeze, Breakout and More Instantly...
Pluristem Therapeutics Inc. Company Name:
PSTI Stock Symbol:
NASDAQ Market:
Pluristem Therapeutics Inc. Website:
HAIFA, Israel, July 25, 2022 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri” or the “Company”) (formerly known as Pluristem Therapeutics, Inc.), a leading biotechnology company, today issued an update to its shareholders from its Chief Executi...
As of July 26 , 2022 , Pluri ’s stock will trade under the symbol PLUR The new name reflects the Company ’s strategy to leverage its innovative 3D cell-based technology to a range of fields, developing cel...
The Company will host an analyst and investor call to discuss the phase III muscle regeneration following hip fracture surgery topline results on July 14 at 9:00 a.m. ET; for registration: https://pluristem.zoom.us/webinar/register/WN_kp_CwQQtR-aFtjAXrdiJpA HAIFA, Israel, Ju...